Sharps disposal: difference between revisions
Diff·revision 14 → 15·14:11, 30 May 2026
Difference between revision 14 and revision 15 of Sharps disposal. 3 lines changed; the page grew by 574 bytes.
| Revision 14 — 13:51, 29 May 2026 AnalyticalAnnie (talk) add see also 8,858 bytes +618 | Revision 15 — 14:11, 30 May 2026 UnitAuditUwe (talk) correct molar mass 9,432 bytes +574 | ||
|---|---|---|---|
| 50 | Injury surveillance adds a second dimension: when injuries occur. Reports from the EPINet surveillance network and from national schemes consistently find that a substantial fraction of injuries occur after use and before disposal — during device disassembly, during transfer to a container, and from sharps left in unexpected places such as bedding, laundry or waste bags. Injuries during disposal itself, including from overfilled containers and from attempts to force a sharp into a full container, form a recognised subgroup.{{r|epinet,elder2006}} | 50 | Injury surveillance adds a second dimension: when injuries occur. Reports from the EPINet surveillance network and from national schemes consistently find that a substantial fraction of injuries occur after use and before disposal — during device disassembly, during transfer to a container, and from sharps left in unexpected places such as bedding, laundry or waste bags. Injuries during disposal itself, including from overfilled containers and from attempts to force a sharp into a full container, form a recognised subgroup.{{r|epinet,elder2006}} |
| 51 | 51 | ||
| + | 52 | This distribution is why the regulatory response is directed at the interval between use and containment rather than at the moment of injection. The prohibition on recapping needles by hand, the requirement that a container be available at the point of use, and the fill-line requirement all address that interval.{{r|osha1910,eu2010}} | |
| + | 53 | ||
| 52 | == References == | 54 | == References == |
| 53 | {{reflist}} | 55 | {{reflist}} |
| ⋮ | ⋮ | ||
| 56 | <ref name="osha1910">Occupational Safety and Health Administration. ''Bloodborne Pathogens'', 29 CFR 1910.1030, as amended by the Needlestick Safety and Prevention Act (2001). United States Department of Labor.</ref> | 58 | <ref name="osha1910">Occupational Safety and Health Administration. ''Bloodborne Pathogens'', 29 CFR 1910.1030, as amended by the Needlestick Safety and Prevention Act (2001). United States Department of Labor.</ref> |
| 57 | <ref name="mmwr2001">Centers for Disease Control and Prevention. "Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis." ''MMWR Recommendations and Reports'' 50(RR-11):1–52 (2001).</ref> | 59 | <ref name="mmwr2001">Centers for Disease Control and Prevention. "Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis." ''MMWR Recommendations and Reports'' 50(RR-11):1–52 (2001).</ref> |
| + | 60 | <ref name="eu2010">Council Directive 2010/32/EU of 10 May 2010 implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector. ''Official Journal of the European Union'' L 134:66–72.</ref> | |
| 58 | <ref name="who2015sharps">World Health Organization. ''WHO Guideline on the Use of Safety-Engineered Syringes for Intramuscular, Intradermal and Subcutaneous Injections in Health Care Settings''. Geneva (2015).</ref> | 61 | <ref name="who2015sharps">World Health Organization. ''WHO Guideline on the Use of Safety-Engineered Syringes for Intramuscular, Intradermal and Subcutaneous Injections in Health Care Settings''. Geneva (2015).</ref> |
| 59 | <ref name="elder2006">Elder A, Paterson C. "Sharps injuries in UK health care: a review of injury rates, viral transmission and potential efficacy of safety devices." ''Occupational Medicine'' 56(8):566–574 (2006).</ref> | 62 | <ref name="elder2006">Elder A, Paterson C. "Sharps injuries in UK health care: a review of injury rates, viral transmission and potential efficacy of safety devices." ''Occupational Medicine'' 56(8):566–574 (2006).</ref> |